BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26968815)

  • 1. Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.
    Gross-Cohen M; Feld S; Naroditsky I; Nativ O; Ilan N; Vlodavsky I
    Oncotarget; 2016 Apr; 7(16):22556-65. PubMed ID: 26968815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.
    Gross-Cohen M; Feld S; Doweck I; Neufeld G; Hasson P; Arvatz G; Barash U; Naroditsky I; Ilan N; Vlodavsky I
    Cancer Res; 2016 May; 76(9):2791-801. PubMed ID: 27013193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of heparanase 2 (Hpa2) in gastric cancer.
    Liu J; Knani I; Gross-Cohen M; Hu J; Wang S; Tang L; Ilan N; Yang S; Vlodavsky I
    Neoplasia; 2021 Sep; 23(9):966-978. PubMed ID: 34343822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression.
    Gross-Cohen M; Yanku Y; Kessler O; Barash U; Boyango I; Cid-Arregui A; Neufeld G; Ilan N; Vlodavsky I
    Matrix Biol; 2021 May; 99():58-71. PubMed ID: 34004353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane.
    Margulis I; Naroditsky I; Gross-Cohen M; Ilan N; Vlodavsky I; Doweck I
    Front Oncol; 2021; 11():645524. PubMed ID: 33959505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase 2 (Hpa2) attenuates the growth of human sarcoma.
    Knani I; Yanku Y; Gross-Cohen M; Ilan N; Vlodavsky I
    Matrix Biol; 2022 Nov; 113():22-38. PubMed ID: 36122821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase 2 (Hpa2) attenuates the growth of pancreatic carcinoma.
    Kayal Y; Singh P; Naroditsky I; Ilan N; Vlodavsky I
    Matrix Biol; 2021 Apr; 98():21-31. PubMed ID: 33839221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.
    Levy-Adam F; Feld S; Cohen-Kaplan V; Shteingauz A; Gross M; Arvatz G; Naroditsky I; Ilan N; Doweck I; Vlodavsky I
    J Biol Chem; 2010 Sep; 285(36):28010-9. PubMed ID: 20576607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.
    Knani I; Singh P; Gross-Cohen M; Aviram S; Ilan N; Sanderson RD; Aronheim A; Vlodavsky I
    Matrix Biol; 2022 Jan; 105():17-30. PubMed ID: 34808335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of heparanase-2 (Hpa2) on cancer and inflammation: Advances and paradigms.
    Vlodavsky I; Hilwi M; Kayal Y; Soboh S; Ilan N
    FASEB J; 2024 May; 38(10):e23670. PubMed ID: 38747803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.
    Doweck I; Feibish N
    Adv Exp Med Biol; 2020; 1221():847-856. PubMed ID: 32274741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase protein and gene expression in bladder cancer.
    Gohji K; Okamoto M; Kitazawa S; Toyoshima M; Dong J; Katsuoka Y; Nakajima M
    J Urol; 2001 Oct; 166(4):1286-90. PubMed ID: 11547059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma.
    Peretti T; Waisberg J; Mader AM; de Matos LL; da Costa RB; Conceição GM; Lopes AC; Nader HB; Pinhal MA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):756-65. PubMed ID: 18617780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation.
    Kayal Y; Barash U; Naroditsky I; Ilan N; Vlodavsky I
    Cell Death Dis; 2023 Jul; 14(7):465. PubMed ID: 37491420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2.
    Gross-Cohen M; Feld S; Arvatz G; Ilan N; Vlodavsky I
    Front Oncol; 2020; 10():627463. PubMed ID: 33585253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of heparanase expression in metastatic melanoma.
    Vornicova O; Boyango I; Feld S; Naroditsky I; Kazarin O; Zohar Y; Tiram Y; Ilan N; Ben-Izhak O; Vlodavsky I; Bar-Sela G
    Oncotarget; 2016 Nov; 7(46):74678-74685. PubMed ID: 27732945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
    Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
    J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.
    Tatsumi Y; Miyake M; Shimada K; Fujii T; Hori S; Morizawa Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase promotes glioma progression via enhancing CD24 expression.
    Barash U; Spyrou A; Liu P; Vlodavsky E; Zhu C; Luo J; Su D; Ilan N; Forsberg-Nilsson K; Vlodavsky I; Yang X
    Int J Cancer; 2019 Sep; 145(6):1596-1608. PubMed ID: 31032901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease.
    Joshi BH; Leland P; Lababidi S; Varrichio F; Puri RK
    Cancer Med; 2014 Dec; 3(6):1615-28. PubMed ID: 25208941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.